AJMC September 15, 2021
Gianna Melillo

The fallout from COVID-19 has spotlighted the limitations of US mental health care, prompting the question if alternative treatments—like psychedelics—could help address current and impending crises. 

As rates of mental illnesses brought on and exacerbated by the COVID-19 pandemic continue to climb, experts are calling for substantial changes to improve mental health care in the United States.

Economic challenges, social isolation, and protracted grief have all contributed to the stark numbers: about 1 in 4 American adults have reported symptoms of anxiety or depressive disorder throughout the pandemic, while health care workers have faced months-long exposure to trauma induced by surges of illness and death.

But largely absent from calls to action is the fact that some pharmacological treatments for mood disorders,...

Today's Sponsors

ZeOmega
Holon
Transcarent

Today's Sponsors

Crossover Health
Qure4u

Today's Sponsor

Institute for Healthcare Improvement

 
Topics: Healthcare System, Mental Health, Patient / Consumer, Provider, Public Health / COVID
How has the COVID-19 pandemic affected mental health?
Chronicling moral distress among healthcare providers during the COVID‐19 pandemic: A longitudinal analysis of mental health strain, burnout, and maladaptive coping behaviours
How COVID-19 changed the delivery of mental health services
Former NIMH Head Says Better Behavioral Health Outcomes Needed Amid COVID, SUD Epidemic
The Surge Of Telehealth During The Pandemic Is Exacerbating Urban-Rural Disparities In Access To Mental Health Care